• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

关于起始颗粒的综述:惰性核心与功能性核心

Review on Starter Pellets: Inert and Functional Cores.

作者信息

Kállai-Szabó Nikolett, Lengyel Miléna, Farkas Dóra, Barna Ádám Tibor, Fleck Christian, Basa Bálint, Antal István

机构信息

Department of Pharmaceutics, Semmelweis University, Hőgyes E. Street 7-9, 1092 Budapest, Hungary.

出版信息

Pharmaceutics. 2022 Jun 18;14(6):1299. doi: 10.3390/pharmaceutics14061299.

DOI:10.3390/pharmaceutics14061299
PMID:35745872
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9227027/
Abstract

A significant proportion of pharmaceuticals are now considered multiparticulate systems. Modified-release drug delivery formulations can be designed with engineering precision, and patient-centric dosing can be accomplished relatively easily using multi-unit systems. In many cases, Multiple-Unit Pellet Systems (MUPS) are formulated on the basis of a neutral excipient core which may carry the layered drug surrounded also by functional coating. In the present summary, commonly used starter pellets are presented. The manuscript describes the main properties of the various nuclei related to their micro- and macrostructure. In the case of layered pellets formed based on different inert pellet cores, the drug release mechanism can be expected in detail. Finally, the authors would like to prove the industrial significance of inert cores by presenting some of the commercially available formulations.

摘要

现在,相当一部分药物被视为多颗粒系统。缓释药物递送制剂可以通过工程精度进行设计,并且使用多单元系统相对容易地实现以患者为中心的给药。在许多情况下,多单元微丸系统(MUPS)是基于中性辅料核心配制的,该核心可能承载着分层药物,周围也有功能性包衣。在本综述中,介绍了常用的起始微丸。该手稿描述了各种核与其微观和宏观结构相关的主要特性。对于基于不同惰性微丸核心形成的分层微丸,药物释放机制可以详细预测。最后,作者希望通过介绍一些市售制剂来证明惰性核心的工业意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/abb6968adddd/pharmaceutics-14-01299-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/31a78c53efcd/pharmaceutics-14-01299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/1cfe97b46d52/pharmaceutics-14-01299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/70568a572ceb/pharmaceutics-14-01299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/196d1ab5c7e0/pharmaceutics-14-01299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/a209d2d9f3a7/pharmaceutics-14-01299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/f3867bb6c1eb/pharmaceutics-14-01299-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/e372af681823/pharmaceutics-14-01299-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/4170db4ad03b/pharmaceutics-14-01299-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/96969a7bf2f8/pharmaceutics-14-01299-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/15767296bde5/pharmaceutics-14-01299-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/1fb1b0d7f817/pharmaceutics-14-01299-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/f42ec8c8966a/pharmaceutics-14-01299-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/abb6968adddd/pharmaceutics-14-01299-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/31a78c53efcd/pharmaceutics-14-01299-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/1cfe97b46d52/pharmaceutics-14-01299-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/70568a572ceb/pharmaceutics-14-01299-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/196d1ab5c7e0/pharmaceutics-14-01299-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/a209d2d9f3a7/pharmaceutics-14-01299-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/f3867bb6c1eb/pharmaceutics-14-01299-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/e372af681823/pharmaceutics-14-01299-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/4170db4ad03b/pharmaceutics-14-01299-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/96969a7bf2f8/pharmaceutics-14-01299-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/15767296bde5/pharmaceutics-14-01299-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/1fb1b0d7f817/pharmaceutics-14-01299-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/f42ec8c8966a/pharmaceutics-14-01299-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b411/9227027/abb6968adddd/pharmaceutics-14-01299-g013.jpg

相似文献

1
Review on Starter Pellets: Inert and Functional Cores.关于起始颗粒的综述:惰性核心与功能性核心
Pharmaceutics. 2022 Jun 18;14(6):1299. doi: 10.3390/pharmaceutics14061299.
2
Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets.使用新型磷酸钙基起始丸粒开发含双氯芬酸钠的双相释放多单元丸粒系统。
Pharmaceutics. 2021 May 28;13(6):805. doi: 10.3390/pharmaceutics13060805.
3
Comparative dissolution study of drug and inert isomalt based core material from layered pellets.层状微丸中药物与惰性异麦芽酮糖醇基核心材料的比较溶出度研究。
J Pharm Biomed Anal. 2014 Sep;98:339-44. doi: 10.1016/j.jpba.2014.06.005. Epub 2014 Jun 10.
4
Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.基于异麦芽糖醇、糖和微晶纤维素惰性核的包衣丸剂药物释放评价。
AAPS PharmSciTech. 2010 Mar;11(1):383-91. doi: 10.1208/s12249-010-9396-x. Epub 2010 Mar 17.
5
Supramolecular elucidation of the quality attributes of microcrystalline cellulose and isomalt composite pellet cores.解析微晶纤维素和异麦芽酮糖醇复合微丸核芯质量属性的超分子结构
J Pharm Biomed Anal. 2013 Oct;84:124-8. doi: 10.1016/j.jpba.2013.04.026. Epub 2013 Apr 25.
6
Suitability of κ-carrageenan pellets for the formulation of multiparticulate tablets with modified release.κ-卡拉胶丸剂作为缓控释多颗粒片剂的配方的适用性。
Int J Pharm. 2011 May 16;409(1-2):9-18. doi: 10.1016/j.ijpharm.2011.02.016. Epub 2011 Feb 16.
7
Dissolution profile of novel composite pellet cores based on different ratios of microcrystalline cellulose and isomalt.基于不同比例微晶纤维素和异麦芽酮糖的新型复合微丸芯的溶出度曲线。
J Pharm Sci. 2012 Aug;101(8):2675-80. doi: 10.1002/jps.23186. Epub 2012 May 9.
8
The Use of Calcium Phosphate-Based Starter Pellets for the Preparation of Sprinkle IR MUPS Formulation of Rosuvastatin Calcium.使用磷酸钙基起始微丸制备瑞舒伐他汀钙速释型多单元微囊系统制剂
Pharmaceuticals (Basel). 2023 Feb 6;16(2):242. doi: 10.3390/ph16020242.
9
A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS).一种用于缓控释药物的灵活技术:多单位微丸系统(MUPS)。
J Control Release. 2010 Oct 1;147(1):2-16. doi: 10.1016/j.jconrel.2010.05.014. Epub 2010 May 19.
10
Development and in vitro evaluation of ketoprofen extended release pellets using powder layering technique in a rotary centrifugal granulator.采用旋转离心制粒机中的粉末分层技术制备酮洛芬缓释微丸及其体外评价
Comb Chem High Throughput Screen. 2011 Feb;14(2):138-45. doi: 10.2174/138620711794474042.

引用本文的文献

1
Fabrication and Evaluation of Isomalt-Based Microfibers as Drug Carrier Systems.基于异麦芽酮糖醇的微纤维作为药物载体系统的制备与评价
Pharmaceutics. 2025 Aug 15;17(8):1063. doi: 10.3390/pharmaceutics17081063.
2
Study on Lyophilised Orodispersible Tablets from Plant-Based Drinks as Bulking Agents.以植物饮料为填充剂的冻干口腔崩解片的研究
Pharmaceutics. 2025 Feb 4;17(2):195. doi: 10.3390/pharmaceutics17020195.
3
The Use of Calcium Phosphate-Based Starter Pellets for the Preparation of Sprinkle IR MUPS Formulation of Rosuvastatin Calcium.

本文引用的文献

1
Development and Dissolution Study of a β-Galactosidase Containing Drinking Straw.含β-半乳糖苷酶吸管的研制与溶出度研究
Pharmaceutics. 2022 Mar 31;14(4):769. doi: 10.3390/pharmaceutics14040769.
2
Targeted oral peptide delivery using multi-unit particulates: Drug and permeation enhancer layering approach.靶向口服肽递药系统:多单位微粒载药和促渗剂层层组装方法。
J Control Release. 2021 Oct 10;338:784-791. doi: 10.1016/j.jconrel.2021.09.002. Epub 2021 Sep 6.
3
Process Analytical Technology Tools for Monitoring Pharmaceutical Unit Operations: A Control Strategy for Continuous Process Verification.
使用磷酸钙基起始微丸制备瑞舒伐他汀钙速释型多单元微囊系统制剂
Pharmaceuticals (Basel). 2023 Feb 6;16(2):242. doi: 10.3390/ph16020242.
用于监测制药单元操作的过程分析技术工具:连续工艺验证的控制策略
Pharmaceutics. 2021 Jun 21;13(6):919. doi: 10.3390/pharmaceutics13060919.
4
Development of a Biphasic-Release Multiple-Unit Pellet System with Diclofenac Sodium Using Novel Calcium Phosphate-Based Starter Pellets.使用新型磷酸钙基起始丸粒开发含双氯芬酸钠的双相释放多单元丸粒系统。
Pharmaceutics. 2021 May 28;13(6):805. doi: 10.3390/pharmaceutics13060805.
5
Assessment of Mini-Tablets Coating Uniformity as a Function of Fluid Bed Coater Inlet Conditions.作为流化床包衣机入口条件函数的微型片剂包衣均匀性评估。
Pharmaceutics. 2021 May 18;13(5):746. doi: 10.3390/pharmaceutics13050746.
6
Image Analysis: A Versatile Tool in the Manufacturing and Quality Control of Pharmaceutical Dosage Forms.图像分析:药物剂型制造与质量控制中的一种通用工具。
Pharmaceutics. 2021 May 10;13(5):685. doi: 10.3390/pharmaceutics13050685.
7
Applications of machine vision in pharmaceutical technology: A review.机器视觉在制药技术中的应用:综述
Eur J Pharm Sci. 2021 Apr 1;159:105717. doi: 10.1016/j.ejps.2021.105717. Epub 2021 Jan 14.
8
Comparative Evaluation of Pellet Cushioning Agents by Various Imaging Techniques and Dissolution Studies.各种成像技术和溶解研究比较颗粒缓冲剂。
AAPS PharmSciTech. 2020 Dec 29;22(1):14. doi: 10.1208/s12249-020-01902-x.
9
3D Printed Microfluidic Devices for Drug Release Assays.用于药物释放分析的3D打印微流控装置。
Pharmaceutics. 2020 Dec 23;13(1):13. doi: 10.3390/pharmaceutics13010013.
10
Oral Fixed-Dose Combination Pharmaceutical Products: Industrial Manufacturing Versus Personalized 3D Printing.口服固定剂量复方制药产品:工业制造与个性化 3D 打印。
Pharm Res. 2020 Jun 17;37(7):132. doi: 10.1007/s11095-020-02847-3.